News

Bristol-Myers Squibb has completed its previously announced $2.4 billion acquisition of Medarex. As a result of the transaction, Medarex has become a wholly-owned subsidiary of Bristol-Myers Squibb. Bristol-Myers

Daiichi Sankyo and Ranbaxy have announced that Terapia, a subsidiary of Ranbaxy in Romania, will market the osteoporosis medication, Evista in Romania. Takashi Shoda, president and CEO of

Vitro Diagnostics, announced advances in its adult stem cell products and technology with application to cell-based therapy of cancer. Vitro’s proprietary stem cell technology and products, now subject

Sagent Pharmaceuticals has announced the launch of adenosine injection, an antiarrhythmic drug used to treat paroxysmal supraventricular tachycardia. Sagent will offer this latex-free, preservative-free adenosine product in 6mg

Mylan has announced that its subsidiary Mylan Pharmaceuticals has launched levalbuterol inhalation solution, 0.25%, (1.25mg/0.5ml). Mylan, which has already launched the product, will market this product with 180

Schering-Plough has introduced Claritin 12-Hour, the 12-hour allergy medicine found in the allergy aisle. New Claritin 12-Hour lasts all day and provides effective, non-drowsy relief from the worst

BioClinica has acquired the CardioNow unit of Agfa HealthCare. With this addition, BioClinica now offers streamlined electronic transport solutions to facilitate the blinding, sharing, tracking and archiving of

PrimerDesign has launched a new test kit for detecting a new drug-resistant strain of the swine flu virus. The mutated virus has been identified in isolated cases in

TransPharma has reported the successful completion of the phase 2A trial of ViaDerm-hPTH(1-34) which is being developed for the treatment of severe osteoporosis. Reportedly, in June 2008, Eli